![](/img/cover-not-exists.png)
PCV72 COST-EFFECTIVENESS OF EXTENDED-RELEASE NICOTINIC ACID/ LAROPIPRANT AS MONOTHERAPY VERSUS EZETIMIBE MONOTHERAPY IN PATIENTS WITH MIXED DYSLIPIDAEMIA IN SCOTLAND
K Jameson, GM Davies, BM Ambegaonkar, V Sazonov, C O'ReganVolume:
13
Year:
2010
Language:
english
DOI:
10.1016/s1098-3015(11)72415-9
File:
PDF, 76 KB
english, 2010